# CaveoVasc System - a New Femoral Vascular Access and Closure Device

> **NCT02694549** · NA · TERMINATED · sponsor: **CaveoMed GmbH** · enrollment: 12 (actual)

## Conditions studied

- Catheterization Via a Femoral Sheath ≤ 6Fr

## Interventions

- **DEVICE:** CaveoVasc

## Key facts

- **NCT ID:** NCT02694549
- **Lead sponsor:** CaveoMed GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-08-09
- **Primary completion:** 2016-10-10
- **Final completion:** 2016-11-10
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2018-08-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02694549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02694549, "CaveoVasc System - a New Femoral Vascular Access and Closure Device". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02694549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*